Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy
- 26 July 2011
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 75 (2), 228-234
- https://doi.org/10.1016/j.lungcan.2011.06.011
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer ChemotherapyMetal-Based Drugs, 2010
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper ChelatorCancer Cell, 2010
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and CarboplatinClinical Cancer Research, 2009
- Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the DrugJournal of Biological Chemistry, 2009
- Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1Molecular Pharmacology, 2008
- Transcription Factor Sp1 Plays an Important Role in the Regulation of Copper Homeostasis in Mammalian CellsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2008
- Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptakeBiochemical Journal, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000